Conditional Tissue-Specific Foxa2 Ablation in Mouse Pancreas Causes Hyperinsulinemic Hypoglycemia

Area of Science:

• Endocrinology
• Developmental Biology
• Genetics

Background:

• Forkhead/winged helix transcription factor Foxa2 is a key regulator of Pdx1, essential for pancreatic development.
• Understanding Foxa2's role in alpha- and beta-cell differentiation is crucial for metabolic disease research.

Purpose of the Study:

• To investigate the role of Foxa2 in pancreatic alpha- and beta-cell development using a conditional knockout model.
• To analyze the impact of Foxa2 deletion on plasma glucose, insulin, and glucagon levels.

Main Methods:

• Generated conditional knockout mice (pdx1-Cre; Foxa2lox/lox) to specifically delete Foxa2 in Pdx1-expressing cells.
• Utilized immunofluorescence microscopy to assess alpha- and beta-cell mass and distribution.
• Measured plasma glucose, insulin, and glucagon levels via chemiluminescence assays and other methods.

Main Results:

• Foxa2 ablation resulted in decreased alpha- and beta-cell density, with a proportional increase in beta cells and loss of alpha cell predominance.
• Heterozygous mutants showed lower insulin levels, while homozygous mutants exhibited profound hypoglucagonemia and hypoglycemia.
• Pdx1 lineage tracing confirmed Foxa2's role in maintaining Pdx1 expression in insulin-secreting beta cells.

Conclusions:

• Homozygous Foxa2 ablation causes significant beta/alpha cell imbalance, hypoglucagonemia, hyperinsulinemia, and hypoglycemia.
• The conditional Foxa2 knockout mouse model is valuable for studying alpha- and beta-cell differentiation and identifying diabetes targets.